A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: A trial of the Eastern Cooperative Oncology Group (E1500)

Kishan J. Pandya, Suzanne Dahlberg, Manuel Hidalgo, Roger B. Cohen, Martin W. Lee, Joan H. Schiller, David H. Johnson

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: A trial of the Eastern Cooperative Oncology Group (E1500)'. Together they form a unique fingerprint.

Medicine & Life Sciences